
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tackling antimicrobial resistance in the COVID-19 pandemic
Haileyesus Getahun, Ingrid Smith, Kavita K. Trivedi, et al.
Bulletin of the World Health Organization (2020) Vol. 98, Iss. 7, pp. 442-442A
Open Access | Times Cited: 296
Haileyesus Getahun, Ingrid Smith, Kavita K. Trivedi, et al.
Bulletin of the World Health Organization (2020) Vol. 98, Iss. 7, pp. 442-442A
Open Access | Times Cited: 296
Showing 1-25 of 296 citing articles:
Towards the sustainable discovery and development of new antibiotics
Marcus Miethke, Marco Pieroni, Tilmann Weber, et al.
Nature Reviews Chemistry (2021) Vol. 5, Iss. 10, pp. 726-749
Open Access | Times Cited: 780
Marcus Miethke, Marco Pieroni, Tilmann Weber, et al.
Nature Reviews Chemistry (2021) Vol. 5, Iss. 10, pp. 726-749
Open Access | Times Cited: 780
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Md Anwarul Azim Majumder, Sayeeda Rahman, Damian Cohall, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 4713-4738
Open Access | Times Cited: 416
Md Anwarul Azim Majumder, Sayeeda Rahman, Damian Cohall, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 4713-4738
Open Access | Times Cited: 416
Increased antimicrobial resistance during the COVID-19 pandemic
Chih‐Cheng Lai, Shey‐Ying Chen, Wen‐Chien Ko, et al.
International Journal of Antimicrobial Agents (2021) Vol. 57, Iss. 4, pp. 106324-106324
Open Access | Times Cited: 370
Chih‐Cheng Lai, Shey‐Ying Chen, Wen‐Chien Ko, et al.
International Journal of Antimicrobial Agents (2021) Vol. 57, Iss. 4, pp. 106324-106324
Open Access | Times Cited: 370
Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome
Thiruchelvi Pulingam, Thaigarajan Parumasivam, Amirah Mohd Gazzali, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 170, pp. 106103-106103
Open Access | Times Cited: 343
Thiruchelvi Pulingam, Thaigarajan Parumasivam, Amirah Mohd Gazzali, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 170, pp. 106103-106103
Open Access | Times Cited: 343
Antimicrobial resistance and COVID-19: Intersections and implications
Gwenan M. Knight, R. E. Glover, Christopher Finn McQuaid, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 281
Gwenan M. Knight, R. E. Glover, Christopher Finn McQuaid, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 281
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
Mentor Ali Ber Lucien, Michael F. Canarie, Paul E. Kilgore, et al.
International Journal of Infectious Diseases (2021) Vol. 104, pp. 250-254
Open Access | Times Cited: 223
Mentor Ali Ber Lucien, Michael F. Canarie, Paul E. Kilgore, et al.
International Journal of Infectious Diseases (2021) Vol. 104, pp. 250-254
Open Access | Times Cited: 223
Antimicrobial resistance in low- and middle-income countries: current status and future directions
Giorgia Sulis, Sena Sayood, Sumanth Gandra
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 2, pp. 147-160
Closed Access | Times Cited: 201
Giorgia Sulis, Sena Sayood, Sumanth Gandra
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 2, pp. 147-160
Closed Access | Times Cited: 201
Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?
Dominique L Monnet, Stephan Harbarth
Eurosurveillance (2020) Vol. 25, Iss. 45
Open Access | Times Cited: 163
Dominique L Monnet, Stephan Harbarth
Eurosurveillance (2020) Vol. 25, Iss. 45
Open Access | Times Cited: 163
Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020
Alexander Ullrich, Madlen Schranz, Ute Rexroth, et al.
The Lancet Regional Health - Europe (2021) Vol. 6, pp. 100103-100103
Open Access | Times Cited: 156
Alexander Ullrich, Madlen Schranz, Ute Rexroth, et al.
The Lancet Regional Health - Europe (2021) Vol. 6, pp. 100103-100103
Open Access | Times Cited: 156
Accelerating antibiotic discovery through artificial intelligence
Marcelo C. R. Melo, Jacqueline R. M. A. Maasch, César de la Fuente‐Núñez
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 147
Marcelo C. R. Melo, Jacqueline R. M. A. Maasch, César de la Fuente‐Núñez
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 147
Lateral flow test engineering and lessons learned from COVID-19
Jobie Budd, Benjamin S. Miller, Nicole E. Weckman, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 1, pp. 13-31
Open Access | Times Cited: 133
Jobie Budd, Benjamin S. Miller, Nicole E. Weckman, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 1, pp. 13-31
Open Access | Times Cited: 133
Coinfections with Other Respiratory Pathogens among Patients with COVID-19
K. Sreenath, Priyam Batra, E. V. Vinayaraj, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 122
K. Sreenath, Priyam Batra, E. V. Vinayaraj, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 122
Antibiotic Discovery and Resistance: The Chase and the Race
Katia Iskandar, Jayaseelan Murugaiyan, Dalal Hammoudi Halat, et al.
Antibiotics (2022) Vol. 11, Iss. 2, pp. 182-182
Open Access | Times Cited: 122
Katia Iskandar, Jayaseelan Murugaiyan, Dalal Hammoudi Halat, et al.
Antibiotics (2022) Vol. 11, Iss. 2, pp. 182-182
Open Access | Times Cited: 122
Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey
Sara Tomczyk, Angelina Taylor, Allison C. Brown, et al.
Journal of Antimicrobial Chemotherapy (2021) Vol. 76, Iss. 11, pp. 3045-3058
Open Access | Times Cited: 120
Sara Tomczyk, Angelina Taylor, Allison C. Brown, et al.
Journal of Antimicrobial Chemotherapy (2021) Vol. 76, Iss. 11, pp. 3045-3058
Open Access | Times Cited: 120
The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries
Yusuff Adebayo Adebisi, Nafisat Dasola Jimoh, Isaac Olushola Ogunkola, et al.
Tropical Medicine and Health (2021) Vol. 49, Iss. 1
Open Access | Times Cited: 112
Yusuff Adebayo Adebisi, Nafisat Dasola Jimoh, Isaac Olushola Ogunkola, et al.
Tropical Medicine and Health (2021) Vol. 49, Iss. 1
Open Access | Times Cited: 112
Biocide-tolerance and antibiotic-resistance in community environments and risk of direct transfers to humans: Unintended consequences of community-wide surface disinfecting during COVID-19?
Bo Chen, Jie Han, Han Dai, et al.
Environmental Pollution (2021) Vol. 283, pp. 117074-117074
Open Access | Times Cited: 108
Bo Chen, Jie Han, Han Dai, et al.
Environmental Pollution (2021) Vol. 283, pp. 117074-117074
Open Access | Times Cited: 108
Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study
Fernando Gordillo Altamirano, Xenia Kostoulias, Dinesh Subedi, et al.
EBioMedicine (2022) Vol. 80, pp. 104045-104045
Open Access | Times Cited: 88
Fernando Gordillo Altamirano, Xenia Kostoulias, Dinesh Subedi, et al.
EBioMedicine (2022) Vol. 80, pp. 104045-104045
Open Access | Times Cited: 88
Baker’s Yeast-Mediated Silver Nanoparticles: Characterisation and Antimicrobial Biogenic Tool for Suppressing Pathogenic Microbes
Salem S. Salem
BioNanoScience (2022) Vol. 12, Iss. 4, pp. 1220-1229
Closed Access | Times Cited: 81
Salem S. Salem
BioNanoScience (2022) Vol. 12, Iss. 4, pp. 1220-1229
Closed Access | Times Cited: 81
Antimicrobial activity of quaternary ammonium salts: structure-activity relationship
Mallikarjuna N. Nadagouda, Pooja Vijayasarathy, Aebin Sin, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 10, pp. 1663-1678
Open Access | Times Cited: 79
Mallikarjuna N. Nadagouda, Pooja Vijayasarathy, Aebin Sin, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 10, pp. 1663-1678
Open Access | Times Cited: 79
Antimicrobial Resistance in Rivers: A Review of the Genes Detected and New Challenges
Paola Grenni
Environmental Toxicology and Chemistry (2022) Vol. 41, Iss. 3, pp. 687-714
Open Access | Times Cited: 75
Paola Grenni
Environmental Toxicology and Chemistry (2022) Vol. 41, Iss. 3, pp. 687-714
Open Access | Times Cited: 75
Antibiotic Resistance during COVID-19: A Systematic Review
Hadi J. Al Sulayyim, Rohani Ismail, Abdullah Al Hamid, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 19, pp. 11931-11931
Open Access | Times Cited: 74
Hadi J. Al Sulayyim, Rohani Ismail, Abdullah Al Hamid, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 19, pp. 11931-11931
Open Access | Times Cited: 74
Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance
Shahana Seher Malik, Sunil Mundra
Antibiotics (2022) Vol. 12, Iss. 1, pp. 45-45
Open Access | Times Cited: 70
Shahana Seher Malik, Sunil Mundra
Antibiotics (2022) Vol. 12, Iss. 1, pp. 45-45
Open Access | Times Cited: 70
Evaluation of the consumption pattern and efficacy of Linezolid in COVID-19 hospitalized patients in a hospital in Tehran-Iran
Ali Rostami, Morteza Izadi, Mohsen Saberi Isfeedvajani, et al.
DARU Journal of Pharmaceutical Sciences (2025) Vol. 33, Iss. 1
Closed Access | Times Cited: 1
Ali Rostami, Morteza Izadi, Mohsen Saberi Isfeedvajani, et al.
DARU Journal of Pharmaceutical Sciences (2025) Vol. 33, Iss. 1
Closed Access | Times Cited: 1
Bacterial co-infections and antibiotic resistance in patients with COVID-19
Hassan Mahmoudi
DOAJ (DOAJ: Directory of Open Access Journals) (2020)
Open Access | Times Cited: 98
Hassan Mahmoudi
DOAJ (DOAJ: Directory of Open Access Journals) (2020)
Open Access | Times Cited: 98
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance
Jesús Rodríguez‐Baño, Gian María Rossolini, Constance Schultsz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 115, Iss. 10, pp. 1122-1129
Open Access | Times Cited: 90
Jesús Rodríguez‐Baño, Gian María Rossolini, Constance Schultsz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 115, Iss. 10, pp. 1122-1129
Open Access | Times Cited: 90